Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

4,363 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Safety and efficacy of intravenous bimagrumab in inclusion body myositis (RESILIENT): a randomised, double-blind, placebo-controlled phase 2b trial.
Hanna MG, Badrising UA, Benveniste O, Lloyd TE, Needham M, Chinoy H, Aoki M, Machado PM, Liang C, Reardon KA, de Visser M, Ascherman DP, Barohn RJ, Dimachkie MM, Miller JAL, Kissel JT, Oskarsson B, Joyce NC, Van den Bergh P, Baets J, De Bleecker JL, Karam C, David WS, Mirabella M, Nations SP, Jung HH, Pegoraro E, Maggi L, Rodolico C, Filosto M, Shaibani AI, Sivakumar K, Goyal NA, Mori-Yoshimura M, Yamashita S, Suzuki N, Katsuno M, Murata K, Nodera H, Nishino I, Romano CD, Williams VSL, Vissing J, Auberson LZ, Wu M, de Vera A, Papanicolaou DA, Amato AA; RESILIENT Study Group. Hanna MG, et al. Among authors: yamashita s. Lancet Neurol. 2019 Sep;18(9):834-844. doi: 10.1016/S1474-4422(19)30200-5. Lancet Neurol. 2019. PMID: 31397289 Clinical Trial.
[Late phase II/III study of BYM338 in patients with sporadic inclusion body myositis (RESILIENT): Japanese cohort data].
Mori-Yoshimura M, Yamashita S, Suzuki N, Katsuno M, Murata K, Nodera H, Teshima R, Inamura T, Nishino I, Aoki M. Mori-Yoshimura M, et al. Among authors: yamashita s. Rinsho Shinkeigaku. 2019 Dec 25;59(12):806-813. doi: 10.5692/clinicalneurol.cn-001325. Epub 2019 Nov 23. Rinsho Shinkeigaku. 2019. PMID: 31761834 Clinical Trial. Japanese.
Multicenter questionnaire survey for sporadic inclusion body myositis in Japan.
Suzuki N, Mori-Yoshimura M, Yamashita S, Nakano S, Murata KY, Inamori Y, Matsui N, Kimura E, Kusaka H, Kondo T, Higuchi I, Kaji R, Tateyama M, Izumi R, Ono H, Kato M, Warita H, Takahashi T, Nishino I, Aoki M. Suzuki N, et al. Among authors: yamashita s. Orphanet J Rare Dis. 2016 Nov 8;11(1):146. doi: 10.1186/s13023-016-0524-x. Orphanet J Rare Dis. 2016. PMID: 27821140 Free PMC article.
The updated retrospective questionnaire study of sporadic inclusion body myositis in Japan.
Suzuki N, Mori-Yoshimura M, Yamashita S, Nakano S, Murata KY, Mori M, Inamori Y, Matsui N, Kimura E, Kusaka H, Kondo T, Ito H, Higuchi I, Hashiguchi A, Nodera H, Kaji R, Tateyama M, Izumi R, Ono H, Kato M, Warita H, Takahashi T, Nishino I, Aoki M. Suzuki N, et al. Among authors: yamashita s. Orphanet J Rare Dis. 2019 Jun 26;14(1):155. doi: 10.1186/s13023-019-1122-5. Orphanet J Rare Dis. 2019. PMID: 31242950 Free PMC article.
Clinical features of Japanese patients with inclusion body myositis.
Hori H, Yamashita S, Tawara N, Hirahara T, Kawakami K, Nishikami T, Maeda Y, Ando Y. Hori H, et al. Among authors: yamashita s. J Neurol Sci. 2014 Nov 15;346(1-2):133-7. doi: 10.1016/j.jns.2014.08.009. Epub 2014 Aug 13. J Neurol Sci. 2014. PMID: 25152387
4,363 results